Comparative Effectiveness of Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors

CompletedOBSERVATIONAL
Enrollment

99,999

Participants

Timeline

Start Date

November 30, 2017

Primary Completion Date

December 17, 2020

Study Completion Date

December 17, 2020

Conditions
Diabetes Mellitus Type 2
Trial Locations (17)

19850

Research Site, Wilmington

Unknown

Research Site, Melbourne

Research Site, Mississauga

Research Site, Gentofte Municipality

Research Site, Espoo

Research Site, Ulm

Research Site, Raanana

Research Site, Rome

Research Site, Tokyo

Research Site, Oslo

Research Site, Porto

Research Site, Singapore

Research Site, Seoul

Research Site, Madrid

Research Site, Södertälje

Research Site, Taipei

Research Site, Luton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT02993614 - Comparative Effectiveness of Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors | Biotech Hunter | Biotech Hunter